Generic of Novo’s GLP-1 arrives in Canada, a ‘test case for the world’
BioSpace
Analysts will be watching as a generic version of semaglutide--marketed by Novo Nordisk as Wegovy for weight loss--launches in Canada as a test case for future price erosion in the U.S.
pharminent
April 29, 2026 (Last updated: April 29, 2026)
BioSpace
Analysts will be watching as a generic version of semaglutide–marketed by Novo Nordisk as Wegovy for weight loss–launches in Canada as a test case for future price erosion in the U.S.
